Corrigendum
Paller CJ, Antonarakis ES. Cabazitaxel: a novel second-line treatment for metastatic castration-resistant prostate cancer.Drug Design, Development and Therapy. 2011;5:117–124. The drug Jevtana was incorrectly named Jentava in Table 4.Original Article
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Dove Medical Press
2011-03-01
|
| Series: | Drug Design, Development and Therapy |
| Online Access: | http://www.dovepress.com/corrigendum-a-novel-second-line-a6787 |